It was reported that lidocaine was exhibited to promote ferroptosis and repress tumor growth of ovarian cancer by regulating miR-382-5p/SLC7A11 axis [32]; PARP inhibition promoted ferroptosis in BRCA mutant ovarian cancer via repressing SLC7A11 [33]. The gene discussed is SLC7A11; the disease is ovarian cancer.